Trial Information

Summary: Assessment of Cardiovascular Risk in HIV Patients

Past research has shown that individuals with HIV may be at greater risk for heart disease than the general population. In this study we will follow HIV-infected men and women and HIV-negative men and women every 6 months over a 2 year period.

The potential benefits from this study include evaluation of overall body composition, cardiovascular health, glucose tolerance, and insulin metabolism. Subjects will be compensated up to $300.

Eligibility criteria include: HIV positive and negative males and females, ages 18-65. Subjects who are HIV positive need to be on a stable treatment regimen for more than 6 months and need to have a CD4 count greater than 350 cells/mm3.

Contact:

Kathleen V Ftch, NP
Massachusetts General Hospital (MGH)
55 Fruit Street
Boston, MA 02114
Telephone: 617-724-8015
Email:

If you would like to learn more about participating in this study, please send an e-mail message using the form below.

*Subject:

Name:

Address:

City:

State:

*Zip:

*Country:

Phone:

*Email address:

Message:

Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 30, 2008 at 5:00:12 PM


Back to Centerwatch Trial Listing by Location


Additional resources
in this illness area

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA